Suppr超能文献

腹膜透析起始时机与死亡率:加拿大器官替换登记处分析。

Timing of peritoneal dialysis initiation and mortality: analysis of the Canadian Organ Replacement Registry.

机构信息

Division of Nephrology, Department of Medicine, Western University, London, ON, Canada.

Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.

出版信息

Am J Kidney Dis. 2014 May;63(5):798-805. doi: 10.1053/j.ajkd.2013.10.054. Epub 2013 Dec 12.

Abstract

BACKGROUND

Several observational studies of hemodialysis patients show an association between early dialysis therapy initiation and increased mortality. Few studies have examined this association among peritoneal dialysis patients.

STUDY DESIGN

Retrospective cohort study.

SETTING & PARTICIPANTS: A cohort of 8,047 incident peritoneal dialysis patients who started dialysis therapy in 2001-2009 and were treated in Canada.

PREDICTOR

Estimated glomerular filtration rate (eGFR) at dialysis therapy initiation. Defined early, mid, and late starts as eGFR>10.5, 7.5-10.5, and <7.5mL/min/1.73m(2), respectively.

OUTCOMES

Time to death.

MEASUREMENTS

Proportional piecewise exponential survival models to compare mortality (overall and early) for the 3 predictor groups.

RESULTS

Between 2001 and 2009, the proportion of patients starting peritoneal dialysis therapy as early starts increased from 29% (95% CI, 26%-32%) to 44% (95% CI, 41%-47%). Compared with the late-start group, the overall mortality rate was not higher for the early- (adjusted HR, 1.08; 95% CI, 0.96-1.23) or mid-start (adjusted HR, 0.96; 95% CI, 0.86-1.09) groups. However, when examined yearly, patients in the early-start group were significantly more likely to die within the first year of dialysis therapy compared with those in the late-start group (adjusted HR, 1.38; 95% CI, 1.10-1.73), but not in subsequent years.

LIMITATIONS

Bias and residual confounding may have influenced the observed relationship between predictor and outcome.

CONCLUSIONS

Patients are initiating peritoneal dialysis therapy at increasingly higher eGFRs. Contrary to most observational studies assessing hemodialysis, the early initiation of peritoneal dialysis therapy, at eGFR>10.5mL/min/1.73m(2), is not associated with increased mortality.

摘要

背景

几项血液透析患者的观察性研究表明,早期透析治疗开始与死亡率增加有关。很少有研究检查过腹膜透析患者的这种关联。

研究设计

回顾性队列研究。

设置和参与者

2001-2009 年开始透析治疗并在加拿大接受治疗的 8047 例新腹膜透析患者队列。

预测因子

透析治疗开始时的估计肾小球滤过率(eGFR)。分别将早期、中期和晚期定义为 eGFR>10.5、7.5-10.5 和<7.5mL/min/1.73m2。

结果

死亡时间。

测量

比例分段指数生存模型比较 3 个预测组的死亡率(总体和早期)。

结果

2001 年至 2009 年间,开始腹膜透析治疗的患者中早期开始治疗的比例从 29%(95%CI,26%-32%)增加到 44%(95%CI,41%-47%)。与晚期开始组相比,早期(调整后的 HR,1.08;95%CI,0.96-1.23)或中期开始(调整后的 HR,0.96;95%CI,0.86-1.09)组的总体死亡率并不更高。然而,每年检查时,与晚期开始组相比,早期开始组的患者在透析治疗的第一年更有可能死亡(调整后的 HR,1.38;95%CI,1.10-1.73),但在随后的几年中并非如此。

局限性

偏倚和残余混杂可能影响了预测因子与结局之间的观察到的关系。

结论

患者开始腹膜透析治疗时的 eGFR 越来越高。与评估血液透析的大多数观察性研究相反,在 eGFR>10.5mL/min/1.73m2 时开始腹膜透析治疗与死亡率增加无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验